Prospects for personalized immunosuppression: pharmacologic tools--a review (Q35757095)

10 August 2017

1 reference

title

Prospects for personalized immunosuppression: pharmacologic tools--a review (English)

1 reference

10 August 2017

1 reference

Del Tacca M

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

Transplantation Proceedings

10 August 2017

published in

1 reference

10 August 2017

volume

36

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

687-689

1 reference

Immunosuppressant drugs--the role of therapeutic drug monitoring

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Therapeutic drug monitoring for immunosuppressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Review of select transplant subpopulations at high risk of failure from standard immunosuppressive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Patient management by Neoral C(2) monitoring: an international consensus statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Dosing and management guidelines for tacrolimus in renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

The temporal profile of calcineurin inhibition by cyclosporine in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Development and application of a high-performance liquid chromatography-based assay for determination of the activity of inosine 5'-monophosphate dehydrogenase in whole blood and isolated mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.03.011

10.1016/J.TRANSPROCEED.2004.03.011

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference